Careteq
- Short interest
- 0.01%
- as of 30 Mar 2023
- Reported shorts
- 14.4K
- Shares on issue
- 120.142M
Careteq (CTQ) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $6.1MM (source: ASX (Markit))vs $7.6MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- −$398.1KM (source: ASX (Markit))vs −$72.2KM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- −$0.001T (source: Derived: trailing 12 months at year end)vs $0.000 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- −20.2%FY
- EPS YoY
- n/aTTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of Careteq - 2026 Annual Report, 27 Aug 2026
Careteq reported total revenue from continuing operations of $6.90 million for the year ended 30 June 2026, down from $8.32 million, and a net loss after tax of $0.40 million (compared to a $0.07 million loss last year). No dividend was declared. The company sold its EHS business, repaid all outstanding loans, and now holds $3.19 million cash to focus on growing its HMR Referrals marketplace platform.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- 100.0%
- Operating margin
- −17.7%
- Net margin
- −6.5%
- FCF margin
- −26.0%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- −4.2×
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $6.1MM (source: ASX (Markit)) | $7.6MM (source: ASX (Markit)) | $7.2M | $5.5M |
| Gross profit | $6.1MT (source: Derived: trailing 12 months at year end) | n/a | $7.2M | $5.1M |
| Operating income | −$1.1MT (source: Derived: trailing 12 months at year end) | n/a | −$1.9M | −$4.8M |
| EBITDA | $28.7KT (source: Derived: trailing 12 months at year end) | n/a | −$804.5K | −$3.5M |
| EBIT | −$259.9KT (source: Derived: trailing 12 months at year end) | n/a | −$1.3M | −$3.9M |
| Interest expense | $256.4KT (source: Derived: trailing 12 months at year end) | n/a | $108.5K | $15.1K |
| Pretax income | −$516.3KT (source: Derived: trailing 12 months at year end) | n/a | −$1.4M | −$3.9M |
| Tax | −$118.2KT (source: Derived: trailing 12 months at year end) | n/a | $330.4K | $171.9K |
| NPAT | −$398.1KM (source: ASX (Markit)) | −$72.2KM (source: ASX (Markit)) | −$2.7M | −$4.3M |
| Net interest income | −$245.2KT (source: Derived: trailing 12 months at year end) | n/a | −$108.5K | −$15.1K |
| EPS basic | −$0.001T (source: Derived: trailing 12 months at year end) | $0.000 | −$0.013 | −$0.031 |
| EPS diluted | −$0.001T (source: Derived: trailing 12 months at year end) | $0.000 | −$0.013 | −$0.031 |
| Shares | n/a | n/a | 237.1M | 141.5M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Careteq - Full Year ResultsFull Year Results27 Aug 2026via asx_announcements
- Careteq - 2026 Annual ReportAnnual Report27 Aug 2026via asx_announcements
- Careteq - Appendix 4EAnnual Results27 Aug 2026via asx_announcements
- CTQ Q4-FY26 Activities Report & Appendix 4CQuarterly Report30 Jul 2026via asx_announcements
- CTQ Q3-FY26 Activities Report & Appendix 4CQuarterly Report30 Apr 2026via asx_announcements
- 1HFY26 Appendix 4D and Half Year ReportHalf Year Results26 Feb 2026via asx_announcements
- CTQ Q2-FY26 Activities Report & Appendix 4CQuarterly Report30 Jan 2026via asx_announcements
- Continue ReadingFinancial Report31 Dec 2025via crawler
- Continue ReadingInvestor Presentation31 Dec 2025via crawler
- Continue ReadingFinancial Report31 Dec 2025via crawler
Showing 10 of 26 reports